Abstract
Total hip arthroplasty remains an extremely reliable treatment of advanced osteoarthritis refractory to conservative management with respect to improvements in pain and function. Despite a relatively small postoperative complication rate, a risk still exists, giving pause to patients and surgeons alike, especially in extremely young, active patients with arthritis. Additionally, some patients with end-stage osteoarthritis are not acceptable surgical candidates, but some form of treatment is required to help mitigate their pain as a long-term solution or to help temporize them until they can be medically optimized to undergo total hip arthroplasty. It is important to review recent advances in nonarthroplasty treatment of hip arthritis, with a focus on nonsurgical options including long acting intra-articular corticosteroid injections, platelet-rich plasma, stem cell therapies, and nerve ablation procedures, and nonarthroplasty surgical options including osteotomies and hip resurfacing.
Original language | English |
---|---|
Title of host publication | Orthopaedic Knowledge Update |
Subtitle of host publication | Hip and Knee Reconstruction 5 |
Publisher | Wolters Kluwer Health |
Pages | 339-344 |
Number of pages | 6 |
ISBN (Electronic) | 9781975123819 |
ISBN (Print) | 9781975123796 |
State | Published - Jan 1 2018 |
Keywords
- Hip arthritis
- Hip resurfacing
- Nerve ablation
- Nonsurgical options
- Platelet-rich plasma